Structured evidence table for Magnesium Pms Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Magnesium Pms Randomized Trial | Moreover, taking such drugs during Ramadan has been reported to increase the risk of cerebral venous thrombosis [], and psychological resistance remains a major global challenge []. | 2 | Iimura Jun (2026) | Novel dietary FemTech based on dietary reference intakes for premenstrual and menstrual disorders: a pilot open-label randomized controlled trial of dietary intervention |
| Magnesium Pms Randomized Trial | For instance, Ahmadi reported that zinc supplementation reduced PMD symptoms [], and Tartagni reported the same for vitamin D []. | 2 | Iimura Jun (2026) | Novel dietary FemTech based on dietary reference intakes for premenstrual and menstrual disorders: a pilot open-label randomized controlled trial of dietary intervention |
| Magnesium Pms Randomized Trial | As summarized by Carlini, there is insufficient evidence to recommend improvements through interventions with a single nutrient []. | 2 | Iimura Jun (2026) | Novel dietary FemTech based on dietary reference intakes for premenstrual and menstrual disorders: a pilot open-label randomized controlled trial of dietary intervention |
| Magnesium Pms Randomized Trial | 1 2 3 4 5 Premenstrual disorder (PMD) is a serious issue for women across cultures, and is a comprehensive concept encompassing both physical and mental symptoms []. | 2 | Iimura Jun (2026) | Novel dietary FemTech based on dietary reference intakes for premenstrual and menstrual disorders: a pilot open-label randomized controlled trial of dietary intervention |
| Magnesium Pms Randomized Trial | PMD significantly impacts the overall health and well-being of women, contributing to higher levels of depression, anxiety, suicidal risk, impaired social and educational/work performance, and lower quality of life [,,–]. | 4 | Krupa Anna Julia (2025) | Zinc, copper, and magnesium in premenstrual disorders: a narrative review |
| Magnesium Pms Randomized Trial | It is estimated that 10% of women with PMDD have bipolar disorder, which poses a 7-fold higher risk compared to women without PMDD []. | 4 | Krupa Anna Julia (2025) | Zinc, copper, and magnesium in premenstrual disorders: a narrative review |
| Magnesium Pms Randomized Trial | Estrogens promote serotonergic transmission by upregulating the expression of the rate-limiting enzyme tryptophan hydroxylase (TPH), thereby increasing tryptophan levels (which is necessary for 5-HT synthesis) and downregulating the expression of the serotonin transporter (SERT), resulting in increased availability of 5-HT in the synaptic cleft [,]. | 4 | Krupa Anna Julia (2025) | Zinc, copper, and magnesium in premenstrual disorders: a narrative review |
| Magnesium Pms Randomized Trial | 1 1 2 3 1 1 4 Premenstrual symptoms refer to both psychological and somatic distress that present in the luteal phase of the menstrual cycle []. | 4 | Krupa Anna Julia (2025) | Zinc, copper, and magnesium in premenstrual disorders: a narrative review |
Source documents